| Item Type | Name |
|
Concept
|
Burkitt Lymphoma
|
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
|
Concept
|
Lymphoma, T-Cell, Peripheral
|
|
Concept
|
Lymphoma, Non-Hodgkin
|
|
Concept
|
Lymphoma, B-Cell
|
|
Concept
|
Lymphoma, Follicular
|
|
Concept
|
Lymphoma, T-Cell, Cutaneous
|
|
Concept
|
Lymphoma
|
|
Concept
|
Lymphoma, Large-Cell, Anaplastic
|
|
Concept
|
Leukemia-Lymphoma, Adult T-Cell
|
|
Concept
|
Lymphoma, Primary Effusion
|
|
Concept
|
Lymphoma, AIDS-Related
|
|
Concept
|
Lymphoma, B-Cell, Marginal Zone
|
|
Concept
|
Lymphoma, Large-Cell, Immunoblastic
|
|
Academic Article
|
Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.
|
|
Academic Article
|
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America.
|
|
Academic Article
|
Peripheral T-cell lymphoma with a regulatory T-cell phenotype: report of a nodal and an extranodal case from Peru.
|
|
Academic Article
|
Extranodal marginal zone lymphoma of the cranial dura mater: report of three cases and systematic review of the literature.
|
|
Academic Article
|
Follicular lymphoma with leukemic phase at diagnosis: a series of seven cases and review of the literature.
|
|
Academic Article
|
Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
|
|
Academic Article
|
EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru.
|
|
Academic Article
|
EBV-positive diffuse large b-cell lymphoma in young immunocompetent individuals.
|
|
Academic Article
|
Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from Peru.
|
|
Academic Article
|
Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients.
|
|
Academic Article
|
Extranodal marginal zone lymphoma from ocular adnexae with subcutaneous involvement.
|
|
Academic Article
|
Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus?
|
|
Academic Article
|
The biology and treatment of plasmablastic lymphoma.
|
|
Academic Article
|
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
|
|
Academic Article
|
EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.
|
|
Academic Article
|
Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?
|
|
Academic Article
|
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management.
|
|
Concept
|
Plasmablastic Lymphoma
|
|
Academic Article
|
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients.
|
|
Academic Article
|
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management.
|
|
Academic Article
|
Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK?+?LBCL): a systematic review of clinicopathological features and management.
|
|
Academic Article
|
Primary cutaneous Epstein-Barr virus-positive B-cell lymphoid proliferation with features of diffuse large B-cell lymphoma and mucocutaneous ulcer: a diagnostic dilemma.
|
|
Academic Article
|
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management.
|
|
Academic Article
|
Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
|
|
Academic Article
|
Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base.
|
|
Academic Article
|
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
|
|
Academic Article
|
Survival outcomes of secondary cancers in patients with Waldenstr?m macroglobulinemia: An analysis of the SEER database.
|
|
Academic Article
|
Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma.
|
|
Academic Article
|
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas.
|
|
Academic Article
|
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study.
|
|
Academic Article
|
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.
|
|
Academic Article
|
Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy.
|
|
Academic Article
|
Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies.
|
|
Academic Article
|
Primary refractory multiple myeloma: a real-world experience with 85 cases.
|
|
Academic Article
|
Cigarette smoking is associated with a small increase in the incidence of non-Hodgkin lymphoma: a meta-analysis of 24 observational studies.
|
|
Academic Article
|
Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma.
|
|
Academic Article
|
Primary refractory Hodgkin lymphoma: limited options and poor survival--but not always.
|
|
Academic Article
|
Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP.
|
|
Academic Article
|
The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP.
|
|
Academic Article
|
PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies.
|
|
Academic Article
|
Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
|
|
Academic Article
|
Extramedullary relapse of acute myeloid leukemia in a surgical wound.
|
|
Academic Article
|
Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base.
|
|
Academic Article
|
Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
|
|
Academic Article
|
Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.
|
|
Academic Article
|
Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.
|
|
Academic Article
|
HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib.
|
|
Academic Article
|
Immunophenotypical Switch versus Tumor Heterogeneity in a Patient with HIV-Associated Diffuse Large B-Cell Lymphoma.
|
|
Academic Article
|
Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies.
|
|
Academic Article
|
Epidemiology of chronic lymphocytic leukemia in Chilean and Amerindian population in Chile.
|
|
Academic Article
|
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients.
|
|
Academic Article
|
SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenstr?m Macroglobulinemia.
|
|
Academic Article
|
Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.
|
|
Academic Article
|
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.
|
|
Academic Article
|
A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL).
|
|
Academic Article
|
Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphoma.
|
|
Academic Article
|
Clinical application of genomics in Waldenstr?m macroglobulinemia.
|
|
Academic Article
|
Medical Management of Hemodynamically Unstable Sinoatrial Node Dysfunction in a Patient With Intracardiac Lymphoma.
|
|
Academic Article
|
Clonal architecture of CXCR4 WHIM-like mutations in Waldenstr?m Macroglobulinaemia.
|
|
Academic Article
|
Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.
|
|
Academic Article
|
Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphoma.
|
|
Academic Article
|
Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified.
|
|
Academic Article
|
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.
|
|
Academic Article
|
Zanubrutinib for the treatment of adults with Waldenstrom macroglobulinemia.
|
|
Academic Article
|
Multiple myeloma in patients up to 30?years of age: a multicenter retrospective study of 52 cases.
|
|
Academic Article
|
Pesticides and non-Hodgkin lymphoma: an overview for the clinician.
|
|
Academic Article
|
A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenstr?m macroglobulinemia.
|
|
Academic Article
|
Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies.
|
|
Academic Article
|
High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy.
|
|
Academic Article
|
The neutrophil-lymphocyte ratio is prognostic in patients with early stage aggressive peripheral T cell lymphoma.
|
|
Academic Article
|
Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease.
|
|
Academic Article
|
Plasmablastic lymphoma: a systematic review.
|
|
Academic Article
|
Management of HIV-associated lymphomas.
|
|
Academic Article
|
Clinicopathologic characteristics and survival of patients with primary effusion lymphoma.
|
|
Academic Article
|
Prognosis in primary effusion lymphoma is associated with the number of body cavities involved.
|
|
Academic Article
|
Diffuse large B-cell lymphoma in human T-lymphotropic virus type 1 carriers.
|
|
Academic Article
|
An international, multicenter, retrospective study on the positive impact of cutaneous involvement on the clinical outcome of adult T-cell leukemia/lymphoma.
|
|
Academic Article
|
Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
|
|
Academic Article
|
Prognostic value of disease risk score versus gait speed in older adults with lymphoma.
|
|
Academic Article
|
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.
|
|
Academic Article
|
The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma.
|
|
Academic Article
|
Plasmablastic lymphoma transformation in a patient with Waldenstr?m macroglobulinemia treated with ibrutinib.
|
|
Academic Article
|
Outcomes of bendamustine- or cyclophosphamide-based first-line chemotherapy in older patients with indolent B-cell lymphoma.
|
|
Academic Article
|
Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas.
|
|
Academic Article
|
Histological transformation to diffuse large B-cell lymphoma in patients with Waldenstr?m macroglobulinemia.
|
|
Academic Article
|
Idelalisib in Waldenstr?m macroglobulinemia: high incidence of hepatotoxicity.
|
|
Academic Article
|
Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies.
|
|
Academic Article
|
Response to ibrutinib in a patient with IgG lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation.
|
|
Academic Article
|
Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma.
|
|
Academic Article
|
Meta-analysis of the association between cigarette smoking and incidence of Hodgkin's Lymphoma.
|
|
Academic Article
|
HIV-negative plasmablastic lymphoma: not in the mouth.
|
|
Academic Article
|
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies.
|
|
Academic Article
|
Complete response to pembrolizumab and radiation in a patient with HIV-negative, EBV-positive plasmablastic lymphoma.
|
|
Academic Article
|
CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.
|
|
Academic Article
|
Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base.
|
|
Academic Article
|
Hematopoietic cell transplantation for plasmablastic lymphoma: a review.
|
|
Academic Article
|
Secondary malignancies in patients with multiple myeloma, Waldenstr?m macroglobulinemia and monoclonal gammopathy of undetermined significance.
|
|
Academic Article
|
Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
|
|
Academic Article
|
CD20-negative diffuse large B-cell lymphoma presenting with lactic acidosis.
|
|
Academic Article
|
Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies.
|
|
Academic Article
|
The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified.
|
|
Academic Article
|
Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype.
|
|
Academic Article
|
Not all aggressive adult T-cell leukemia/lymphoma subtypes are created equal.
|
|
Academic Article
|
Risk factors associated with Clostridium difficile infection in adult oncology patients with a history of recent hospitalization for febrile neutropenia.
|
|
Academic Article
|
Acute Myeloid Leukemia Evolving from JAK 2-Positive Primary Myelofibrosis and Concomitant CD5-Negative Mantle Cell Lymphoma: A Case Report and Review of the Literature.
|
|
Academic Article
|
Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos.
|
|
Academic Article
|
Bruton tyrosine kinase inhibitors in the management of Waldenstr?m macroglobulinemia.
|
|
Academic Article
|
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
|
|
Academic Article
|
Diffuse Large B-Cell Lymphoma in Chile: The Impact of Combined CHOP Plus Rituximab in the Public Health System.
|
|
Academic Article
|
The prognostic role of red cell distribution width on all-cause and cause-specific outcomes in peripheral T-cell lymphoma: a retrospective cohort study.
|
|
Academic Article
|
Real-world experience in older patients with diffuse large B-cell lymphoma treated in Latin America: A study by the Latin American study group of lymphoproliferative disorders (GELL).
|
|
Academic Article
|
Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibition.
|
|
Academic Article
|
Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same patient: a case series and literature review.
|